Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Brousseau

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Vaccine|September 27, 2024
Effectiveness of the ten- and thirteen-valent pneumococcal conjugate vaccines to prevent serotype 19A invasive pneumococcal disease in Quebec, Canada. A Canadian immunization research network (CIRN) studyGeneviève Deceuninck, Nicholas Brousseau, Brigitte Lefebvre, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|January 9, 2025
Burden of disease of respiratory syncytial virus in older adults and adults considered at high risk of severe infectionElissa M Abrams, Pamela Doyon-Plourde, Phaedra Davis, et al.
Vaccine|July 31, 2023
Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent serotype 3 invasive pneumococcal disease in Quebec in children, CanadaGeneviève Deceuninck, Nicholas Brousseau, Brigitte Lefebvre, et al.
Pediatrics|October 23, 2013
Measles in children vaccinated with 2 doses of MMRFannie Defay, Gaston De Serres, Danuta M Skowronski, et al.
Vaccine|September 27, 2023
Clonal diversity of Streptococcus pneumoniae serotype 19A collected from children < 5 years old in Québec, Canada, 2016-2021Alyssa R Golden, Brigitte Lefebvre, Geneviève Deceuninck, et al.
BMC Infectious Diseases|April 10, 2026
Serotype-specific pneumococcal conjugate vaccine effectiveness in Canadian children: an indirect cohort study using Bayesian hierarchical modeling of multisite dataZhou Zhou, Geneviève Deceuninck, Nicholas Brousseau, et al.
Vaccine|October 10, 2023
Tdap vaccine in pregnancy and immunogenicity of pertussis and pneumococcal vaccines in children: What is the impact of different immunization schedules?Yossi Febriani, Thowiba Mansour, Manish Sadarangani, et al.
Vaccine|December 26, 2025
Immune memory assessment three years following a single dose of hepatitis a vaccine at 12, 13 or 19 months of ageYossi Febriani, Marie-Michelle Ursu, Chantal Sauvageau, et al.
BMC Pregnancy and Childbirth|June 13, 2022
Do intentions lead to action? Results of a longitudinal study assessing determinants of Tdap vaccine uptake during pregnancy in Quebec, CanadaEve Dubé, Marie-Eve Trottier, Maryline Vivion, et al.
The Journal of Infectious Diseases|February 25, 2026
Immunogenicity of two versus three doses of hepatitis B vaccine when administered to children aged 2-18 months: a randomized clinical trialKoffi Barnabé Kegbevi, Yossi Febriani, Chantal Sauvageau, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Vaccine|September 27, 2024
Effectiveness of the ten- and thirteen-valent pneumococcal conjugate vaccines to prevent serotype 19A invasive pneumococcal disease in Quebec, Canada. A Canadian immunization research network (CIRN) studyGeneviève Deceuninck, Nicholas Brousseau, Brigitte Lefebvre, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|January 9, 2025
Burden of disease of respiratory syncytial virus in older adults and adults considered at high risk of severe infectionElissa M Abrams, Pamela Doyon-Plourde, Phaedra Davis, et al.
Vaccine|July 31, 2023
Effectiveness of thirteen-valent pneumococcal conjugate vaccine to prevent serotype 3 invasive pneumococcal disease in Quebec in children, CanadaGeneviève Deceuninck, Nicholas Brousseau, Brigitte Lefebvre, et al.
Pediatrics|October 23, 2013
Measles in children vaccinated with 2 doses of MMRFannie Defay, Gaston De Serres, Danuta M Skowronski, et al.
Vaccine|September 27, 2023
Clonal diversity of Streptococcus pneumoniae serotype 19A collected from children < 5 years old in Québec, Canada, 2016-2021Alyssa R Golden, Brigitte Lefebvre, Geneviève Deceuninck, et al.
BMC Infectious Diseases|April 10, 2026
Serotype-specific pneumococcal conjugate vaccine effectiveness in Canadian children: an indirect cohort study using Bayesian hierarchical modeling of multisite dataZhou Zhou, Geneviève Deceuninck, Nicholas Brousseau, et al.
Vaccine|October 10, 2023
Tdap vaccine in pregnancy and immunogenicity of pertussis and pneumococcal vaccines in children: What is the impact of different immunization schedules?Yossi Febriani, Thowiba Mansour, Manish Sadarangani, et al.
Vaccine|December 26, 2025
Immune memory assessment three years following a single dose of hepatitis a vaccine at 12, 13 or 19 months of ageYossi Febriani, Marie-Michelle Ursu, Chantal Sauvageau, et al.
BMC Pregnancy and Childbirth|June 13, 2022
Do intentions lead to action? Results of a longitudinal study assessing determinants of Tdap vaccine uptake during pregnancy in Quebec, CanadaEve Dubé, Marie-Eve Trottier, Maryline Vivion, et al.
The Journal of Infectious Diseases|February 25, 2026
Immunogenicity of two versus three doses of hepatitis B vaccine when administered to children aged 2-18 months: a randomized clinical trialKoffi Barnabé Kegbevi, Yossi Febriani, Chantal Sauvageau, et al.
Pageof 6